Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Madrigal Pharmaceuticals (MDGL) Return on Assets (2019 - 2025)

Historic Return on Assets for Madrigal Pharmaceuticals (MDGL) over the last 14 years, with Q3 2025 value amounting to 0.24%.

  • Madrigal Pharmaceuticals' Return on Assets rose 2400.0% to 0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24%, marking a year-over-year increase of 2400.0%. This contributed to the annual value of 0.55% for FY2024, which is 1900.0% up from last year.
  • Latest data reveals that Madrigal Pharmaceuticals reported Return on Assets of 0.24% as of Q3 2025, which was up 2400.0% from 0.28% recorded in Q2 2025.
  • Over the past 5 years, Madrigal Pharmaceuticals' Return on Assets peaked at 0.24% during Q3 2025, and registered a low of 1.46% during Q3 2022.
  • Moreover, its 5-year median value for Return on Assets was 0.75% (2021), whereas its average is 0.77%.
  • Per our database at Business Quant, Madrigal Pharmaceuticals' Return on Assets crashed by -7100bps in 2022 and then skyrocketed by 8100bps in 2024.
  • Madrigal Pharmaceuticals' Return on Assets (Quarter) stood at 0.84% in 2021, then plummeted by -35bps to 1.13% in 2022, then grew by 25bps to 0.85% in 2023, then surged by 48bps to 0.44% in 2024, then soared by 45bps to 0.24% in 2025.
  • Its Return on Assets was 0.24% in Q3 2025, compared to 0.28% in Q2 2025 and 0.38% in Q1 2025.